Clinicopathological observation of interventional neoadjuvant chemotherapy in patients with stage Ⅲ non-small cell lung cancer

Objective To evaluate the clinical and pathohistological response of the interventional (bronchial artery infusion, BAI) neoadjuvant chemotherapy for the patients with stage Ⅲ non-small cell lung cancer (NSCLC). Methods 36 patients with stage Ⅲ NSCLC were treated by BAI chemotherapy for 1～3 courses, and then underwent surgery. Clinical and pathohistological response were analyzed. Results The clinical response rate (RR) was 55.6% . Clinical RR was higher significantly in patients who had received 2 and...